Free shipping on all orders over $ 500

WYC-209

Cat. No. M10507

All AbMole products are for research use only, cannot be used for human consumption.

WYC-209 Structure
Synonym:

WYC209

Size Price Availability Quantity
5mg USD 70  USD70 In stock
10mg USD 105  USD105 In stock
25mg USD 210  USD210 In stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

WYC-209 is a novel inhibitor of tumor-repopulating cells (trcs), inducing trc apoptosis primarily via the caspase 3 pathway. WYC-209 induces apoptosis primarily via the caspase 3 pathway with IC50 of 0.19 μM for inmalignant murine melanoma TRCs.

In vivo, WYC-209 (0.022-0.22 mg/kg; i.v.; once every two days for 25 days) inhibits tumor metastasis in C57BL/6 mice bearing lung metastases.

Protocol (for reference only)
Cell Experiment
Cell lines A2780, A549, MCF-7, MDA-MB-435s, A375 cells
Preparation method Human ovarian cancer A2780 (a), human lung cancer A549 (b), human breast cancer MCF-7 (c), human melanoma MDA-MB-435s (d), and human malignant melanoma A375 (e) were cultured in 90-Pa fibrin gels for 3 days and treated with 0.1, 1, or 10 μM WYC-209. f–j A2780, A549, MCF-7, MDA-MB-435s, and A375 were cultured in 90-Pa fibrin gels for 3 days, treated with 10 μM WYC-209, and were then washed out of the compound on day 4.
Concentrations 10 μM
Incubation time 24 hours
Animal Experiment
Animal models Female immune-competent C57BL/6 mice
Formulation 0.1% DMSO
Dosages 0.022, 0.22 mg/kg
Administration intravenously injected; once every two days for 25 days
Chemical Information
Molecular Weight 368.45
Formula C20H20N2O3S
CAS Number 2131803-90-0
Solubility (25°C) DMSO 70 mg/mL
Storage Powder          -20°C   3 years ;  4°C   2 years
In solvent       -80°C   6 months ;  -20°C   1 month
References

[1] Junwei Chen, et al. Nat Commun. Inhibition of cancer stem cell like cells by a synthetic retinoid

Related RAR/RXR Products
YCT529 

YCT529 is a potent, selective and orally active RAR-α inhibitor.

LG101506 

LG101506 is a selective and orally active RXR modulator with a Ki of 2.7 nM for RXRα.

ER 50891 

ER-50891 is a potent antagonist of retinoic acid receptor α(RARα).

LG100754

LG100754 (UVI 2112) is a RXR dimers modulater.

AGN 196996 

AGN 196996 is a potent and selective RARα antagonist with Ki value of 2 nM; little binding affinity for RARβ(Ki=1087 nM) and RARγ(Ki=8523 nM).

  Catalog
Abmole Inhibitor Catalog




Keywords: WYC-209, WYC209 supplier, RAR/RXR, inhibitors, activators

All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.